Description
RESEARCH PEPTIDE STACK
GLP2-TRZ
GLP-2 & TIRZEPATIDE COMBINATION RESEARCH FORMULATION
GLP2-TRZ IS A RESEARCH FORMULATION COMBINING GLUCAGON-LIKE PEPTIDE-2 (GLP-2) ACTIVITY WITH TIRZEPATIDE’S DUAL GLP-1/GIP RECEPTOR AGONIST PROFILE. GLP-2 HAS BEEN INDEPENDENTLY STUDIED FOR ITS ROLE IN INTESTINAL MUCOSAL GROWTH, GUT BARRIER INTEGRITY, AND NUTRIENT ABSORPTION SIGNALING. COMBINED WITH TIRZEPATIDE’S METABOLIC RECEPTOR ACTIVITY, THIS FORMULATION HAS BEEN OF INTEREST TO RESEARCHERS STUDYING THE INTERSECTION OF GASTROINTESTINAL BIOLOGY AND METABOLIC SIGNALING.
SCIENTISTS INVESTIGATING ENTEROCYTE PROLIFERATION, GUT EPITHELIAL MAINTENANCE, AND CONCURRENT METABOLIC PATHWAY MODULATION HAVE USED THIS COMPOUND COMBINATION IN PRECLINICAL RESEARCH SETTINGS. THE DUAL MECHANISM OFFERS A RESEARCH TOOL FOR STUDYING COMPLEMENTARY GASTROINTESTINAL AND ENDOCRINE SIGNALING IN MODELS OF GUT HEALTH AND METABOLIC DYSFUNCTION.
⚠ LEGAL DISCLAIMER — FOR RESEARCH USE ONLY
THIS PRODUCT IS INTENDED STRICTLY FOR RESEARCH PURPOSES ONLY. IT IS NOT INTENDED FOR HUMAN CONSUMPTION, VETERINARY USE, OR ANY OTHER USE. THIS PRODUCT HAS NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION (FDA). IT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR MEDICAL CONDITION. FOR USE BY LICENSED RESEARCH PROFESSIONALS ONLY.
